Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib (vol 13, pg 1708, 2024)

被引：0
|
作者：
Hu, Kui [2 ]
Dong, Shuang [1 ]
Li, Xiaoyu [1 ]
Hu, Sheng [1 ]
Deng, Wenyou [2 ]
Ou, Wuling [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Thorac Inner Dept 1, Zhuodaoquan St 116, Wuhan 430079, Peoples R China
[2] Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2025年 / 14卷 / 02期
关键词：
D O I：
10.21037/tlcr-2024-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：652 / 652
页数：1
相关论文
共 50 条
  • [1] Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib
    Cai, Qian
    Hu, Kui
    Dong, Shuang
    Li, Xiaoyu
    Hu, Sheng
    Deng, Wenyou
    Ou, Wulin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07) : 1708 - 1717
  • [2] Lung cavitation in lung metastases of gastric and non-small-cell lung cancer patients treated with apatinib
    Cecere, Fabiana Letizia
    Aguilar, Andres
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (04) : 317 - 318
  • [3] Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer
    Tian, Wentao
    Cao, Chenghui
    Shu, Long
    Wu, Fang
    ONCOTARGETS AND THERAPY, 2020, 13 : 12113 - 12129
  • [4] Enhanced Anti-Tumor And Anti-Angiogenic Effects Of Apatinib Combined With Chemotherapy In A Zebrafish Model Of Non-Small Cell Lung Cancer
    Zhang, W.
    Wu, Z.
    Qian, Z.
    Zhou, J.
    Wang, W.
    Wang, X.
    Liu, J.
    Feng, Y.
    Zhou, M.
    Li, Q.
    Shi, G.
    Gao, B.
    Xiang, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A 'Hard Days Night'
    Pilotto, Sara
    Bonomi, Maria
    Massari, Francesco
    Milella, Michele
    Ciuffreda, Ludovica
    Brunelli, Matteo
    Fassan, Matteo
    Chilosi, Marco
    Scarpa, Aldo
    Tortora, Giampaolo
    Bria, Emilio
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (24) : 3958 - 3972
  • [6] Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)
    Tan, Aaron C.
    Pavlakis, Nick
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [7] Advances in Predictive Biomarkers for Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer
    Zhao, Weixing
    Jiang, Jun
    CANCER CONTROL, 2024, 31
  • [8] Enhanced antitumor and anti-angiogenic effects of Apatinib combined with chemotherapy in a zebrafish model of non-small cell lung cancer
    Xiang, Yi
    Zhang, Wenchao
    Wu, Zhuanbin
    Qian, Zijun
    Zhou, Jianping
    Wang, Xiaofei
    Wang, Weiqin
    Zhou, Ling
    Liu, Jing
    Feng, Yun
    Zhou, Min
    Shi, Guochao
    Gao, Beili
    CANCER RESEARCH, 2017, 77
  • [9] Anti-angiogenic agents in the treatment of non-small cell lung cancer
    Szyszka-Barth, Katarzyna
    Ramlau, Katarzyna
    Stencel, Dariusz
    Ramlau, Rodryg
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 11 (02) : 145 - 150
  • [10] Evaluation of Anti-Angiogenic Therapy Combined with Immunotherapy and Chemotherapy as a Strategy to Treat Locally Advanced and Metastatic Non-Small-Cell Lung Cancer
    Abdallah, Mahmoud
    Voland, Rick
    Decamp, Malcolm
    Flickinger, John
    Pacioles, Toni
    Jamil, Muhammad
    Silbermins, Damian
    Shenouda, Mina
    Valsecchi, Matias
    Bir, Arvinder
    Shweihat, Yousef
    Bastidas, Juan
    Chowdhury, Nepal
    Kachynski, Yury
    Eldib, Howide
    Wright, Thomas
    Mahdi, Ahmad
    Al-Nusair, Jowan
    Nwanwene, Kemnasom
    Varlotto, John
    CANCERS, 2024, 16 (24)
12345